FN1 and neoplasm: Cy5-labelled CTVRTSADC demonstrated increased binding to upregulated EDB-fibronectin in prostate cancer (PC3) cells in vitro and in vivo following intravenous injection in nude mice bearing PC3-GFP tumour xenografts.